Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome

Overview of attention for article published in Drug Design, Development and Therapy, April 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 7 publications that cite this research output.

7

The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.

Gene Expression and DNA Methylation Profiling Suggest Potential Biomarkers for Azacitidine Resistance in Myelodysplastic Syndrome

Article in International Journal of Molecular Sciences (April 2024)

A Chinese medicine formula(Sanzi-huangshi pill) as an adjuvant therapy for lower-risk myelodysplastic syndrome: protocol for a prospective, randomized, open-label, blinded-endpoint (PROBE) trial

Preprint in Research Square (June 2023)

Efficacy and safety of Sanzi-huangshi pill as an adjuvant therapy in lower-risk myelodysplastic syndrome: study protocol for a multi- center randomized controlled trial

Preprint in Research Square (March 2023)